| Scalable manufacturing of CAR T cells for cancer immunotherapy M Abou-el-Enein, M Elsallab, SA Feldman, AD Fesnak, HE Heslop, ... Blood cancer discovery 2 (5), 408-422, 2021 | 183 | 2021 |
| Concise review: a comprehensive analysis of reported adverse events in patients receiving unproven stem cell-based interventions G Bauer, M Elsallab, M Abou-El-Enein Stem cells translational medicine 7 (9), 676-685, 2018 | 163 | 2018 |
| CAR T-cell product performance in haematological malignancies before and after marketing authorisation M Elsallab, BL Levine, AS Wayne, M Abou-El-Enein The Lancet Oncology 21 (2), e104-e116, 2020 | 81 | 2020 |
| Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System M Elsallab, M Ellithi, MA Lunning, C D’Angelo, J Ma, MA Perales, ... Blood 143 (20), 2099-2105, 2024 | 59 | 2024 |
| Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals M Elsallab, CA Bravery, A Kurtz, M Abou-El-Enein Molecular Therapy-Methods & Clinical Development, 2020 | 47 | 2020 |
| Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis M Elsallab, M Ellithi, S Hempel, H Abdel-Azim, M Abou-el-Enein Cancer Gene Therapy 30 (6), 845-854, 2023 | 34 | 2023 |
| Expanding access to CAR T cell therapies through local manufacturing M Elsallab, MV Maus Nature biotechnology 41 (12), 1698-1708, 2023 | 29 | 2023 |
| Post-marketing safety and efficacy surveillance of cell and gene therapies in the EU: A critical review E Fritsche, M Elsallab, M Schaden, SP Hey, M Abou-El-Enein Cell Gene Ther. Insights 5 (11), 1505-21, 2019 | 21 | 2019 |
| Detection of SARS‐CoV‐2‐specific memory B cells to delineate long‐term COVID‐19 immunity CJ Thieme, M Abou‐el‐Enein, E Fritsche, M Anft, K Paniskaki, ... Allergy 76 (8), 2595, 2021 | 10 | 2021 |
| CAR NK-92 cell–mediated depletion of residual TCR+ cells for ultrapure allogeneic TCR-deleted CAR T-cell products J Kath, W Du, S Martini, M Elsallab, C Franke, L Hartmann, V Drosdek, ... Blood Advances 7 (15), 4124-4134, 2023 | 6 | 2023 |
| Linking scattered stem cell-based data to advance therapeutic development A Kurtz, M Elsallab, R Sanzenbacher, M Abou-El-Enein Trends in Molecular Medicine 25 (1), 8-19, 2019 | 4 | 2019 |
| National survey of FACT-accredited cell processing facilities: assessing preparedness for local manufacturing of immune effector cells M Elsallab, F Bourgeois, MV Maus Transplantation and Cellular Therapy 30 (6), 626. e1-626. e11, 2024 | 3 | 2024 |
| ACT To Sustain: Adoptive Cell Therapy To Sustain access to non-commercialized genetically modified cell therapies RA Gardner, C White, M Elsallab, S Farnia, E Fraint, B Grilley, ... Transplantation and Cellular Therapy, 2024 | 2 | 2024 |
| Neurotoxicity and Rare Adverse Events in BCMA-Directed CAR T Cell Therapy: A Comprehensive Analysis of Real-World FAERS Data M Ellithi, M Elsallab, MA Lunning, SA Holstein, S Sharma, JQ Trinh, J Ma, ... Transplantation and Cellular Therapy 31 (2), 71. e1-71. e14, 2025 | 1 | 2025 |
| Autologous Anti CD-19 Chimeric Antigen Receptor T cells in Relapsed or Refractory Acute Lymphoblastic Leukemia: A Systematic Review and Meta-analysis. M Elsallab, M Ellithi, M Abou-el-Enein OSF, 2022 | 1 | 2022 |
| Charting the course for CAR T-cell manufacturing M Elsallab, MV Maus Blood Advances 8 (23), 6131-6132, 2024 | | 2024 |
| Investigating and Guiding Evidence Generation to Inform Regulatory Decision-Making for Advanced Therapy Medicinal Products (ATMPs) M Elsallab | | 2021 |
| Comparison of Clinical Evidence Submitted to the FDA and EMA for Cell and Gene Therapies M Elsallab, S Gillner, FT Bourgeois JAMA Internal Medicine, 0 | | |
| Mapping the Clinical Development Trajectory of Cell and Gene Therapy Products M Elsallab, M Ouvina, A Arfe, FT Bourgeois Clinical Pharmacology & Therapeutics, 0 | | |
Mohamed Abou-el-EneinKeck School of Medicine USCVerified email at med.usc.edu